You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small molecule

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nutrition, Healthy Trial in Re?ovot (nutritional)

Recruiting
  • Nutrition, Healthy
  • nutritional
  • Reẖovot, Israel
    Weizmann Institute of Science
Jul 16, 2023

Neurodegenerative Diseases Trial (SMARTO ONE, )

Not yet recruiting
  • Neurodegenerative Diseases
  • SMARTO ONE
  • placebo
  • (no location specified)
Jul 14, 2023

Neurodegenerative Diseases Trial (SMARTO ONE)

Not yet recruiting
  • Neurodegenerative Diseases
  • SMARTO ONE
  • (no location specified)
Jul 14, 2023

Small Molecule LCDM and GV Oocyte

Not yet recruiting
  • Assisted Reproduction
  • Small molecule LCDM
  • (no location specified)
Apr 26, 2022

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 6, 2023

Breast Cancer Trial in Guangzhou (Take probiotics)

Recruiting
  • Breast Cancer
  • Take probiotics
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 6, 2023

Retinitis Pigmentosa Trial (KIO-301)

Recruiting
  • Retinitis Pigmentosa
  • Adelaide, South Australia, Australia
    Royal Adeliade Hospital
Dec 22, 2022

Biologics or Small Molecule Therapies in Inflammatory Bowel

Completed
  • Crohn's Disease
  • Ulcerative Colitis
    • New York, New York
    • +1 more
    Jan 9, 2023

    Exploratory Drug Interaction Study Between SMIs and DOACs

    Recruiting
    • Solid Tumor
    • Cancer, Lung
      • Nijmegen, Gelderland, Netherlands
      • +1 more
      Feb 7, 2023

      COVID-19 Trial (STI-1558)

      Not yet recruiting
      • COVID-19
      • (no location specified)
      Sep 15, 2023

      Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • TACE（transcatheter arterial chemoembolization）
      • +2 more
      • (no location specified)
      Jun 5, 2023

      Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

      Not yet recruiting
      • Metastatic Solid Tumor
      • +4 more
      • San Francisco, California
        University of California, San Francisco
      Jan 12, 2023

      Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)

      Recruiting
      • Nasopharyngeal Cancer
      • Epstein-Barr Virus Related Carcinoma
      • Stanford, California
        Stanford University
      Mar 31, 2022

      Filariasis, Lymphatic, Onchocerciasis Trial in Liverpool (AWZ1066S, Placebo)

      Not yet recruiting
      • Filariasis, Lymphatic
      • Onchocerciasis
      • Liverpool, Merseyside, United Kingdom
        Liverpool University Hospitals NHS Foundation Trust
      Oct 19, 2021

      Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

      Recruiting
      • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
      • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
      • Shanghai, Shanghai, China
        Shanghai Renji Hospital
      Sep 12, 2023

      Alzheimer Trial in Santa Monica (NE3107)

      Completed
      • Alzheimer Disease
      • Santa Monica, California
        Neurological Associates - The Interventional Group
      Sep 26, 2022

      AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

      Terminated
      Has Results
      • AML Including AML de Novo and AML Secondary to MDS
      • DLBCL
      • Birabresib Dose 20 mg
      • (no location specified)
      Aug 23, 2022

      Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumor
      • Pancreas Cancer
      • cytoreductive surgery
      • +2 more
      • Chicago, Illinois
        The University of Chicago
      Nov 8, 2022

      Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

      Recruiting
      • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
      • +2 more
      • Beijing, Beijing, China
      • +1 more
      Nov 21, 2023

      Primary Sclerosing Cholangitis Trial in Phoenix, Tempe, Rochester (Vidofludimus calcium)

      Completed
      Has Results
      • Primary Sclerosing Cholangitis
      • Vidofludimus calcium
      • Phoenix, Arizona
      • +2 more
      Oct 11, 2022

      Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

      Active, not recruiting
      • Ovarian Neoplasms
      • +2 more
      • KU-0059436 (AZD2281)(PARP inhibitor)
      • Brussels, Belgium
      • +4 more
      Dec 19, 2022

      B-Cell Lymphoma Trial in United States (CPI-1205)

      Completed
      • B-Cell Lymphoma
      • Lafayette, Indiana
      • +5 more
      May 16, 2022

      Metastatic Prostate Adenocarcinoma Trial in New York (68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator)

      Completed
      • Metastatic Prostate Adenocarcinoma
      • 68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator
      • New York, New York
        Weill Cornell Medicine
      Feb 1, 2022

      Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent Trial in United States (RGX-104, Nivolumab, Ipilimumab)

      Recruiting
      • Endometrial Cancer
      • +5 more
      • Los Angeles, California
      • +13 more
      Jul 21, 2022

      Cancer of Pancreas, Cancer of the Pancreas, Tumors, Pancreatic Trial in Boston, New York (Talabostat Mesylate)

      Withdrawn
      • Cancer of Pancreas
      • +4 more
      • Talabostat Mesylate
      • Boston, Massachusetts
      • +1 more
      Feb 8, 2022